mhurhangee/ep-ind-claims huggingface dataset:
Vehicle headlight system for the generation of directed illumination radiation in a space, wherein the vehicle headlight system comprises a plurality of LED lamp elements for together producing a luminance pattern, wherein each LED lamp element comprises an LED element and a collimator assigned to the LED element, for producing a cone of light, and wherein each collimator has a truncated pyramid shape with such a cross section, or with such a base surface, that the LED lamp elements can border directly next to each other, wherein each cone of light is arranged to illuminate a separate spatial area, wherein the luminance pattern is formed by adding the cones of light next to each other, wherein the vehicle headlight system further comprises a common secondary optics device for imaging the luminance pattern in the space, the plurality of LED lamp elements being arranged in two dimensions such that together they irradiate the common secondary optics device, wherein each collimator has a longitudinal axis and a light emission opening, characterized in that the LED lamp elements are arranged such that the light emission openings of the collimators are focused on a common point of the common secondary optics device, either by the longitudinal axes of the collimators being inclined to a normal on a base surface of the LED lamp elements, or by the LED lamp elements being arranged next to each other in such a manner that their base surfaces form a curved surface. each cone of light is arranged to illuminate a separate spatial area, wherein the luminance pattern is formed by adding the cones of light next to each other, wherein the vehicle headlight system further comprises a common secondary optics device for imaging the luminance pattern in the space, the plurality of LED lamp elements being arranged in two dimensions such that together they irradiate the common secondary optics device, wherein each collimator has a longitudinal axis and a light emission opening, characterized in that the LED lamp elements are arranged such that the light emission openings of the collimators are focused on a common point of the common secondary optics device, either by the longitudinal axes of the collimators being inclined to a normal on a base surface of the LED lamp elements, or by the LED lamp elements being arranged next to each other in such a manner that their base surfaces form a curved surface.
Method for producing a lactic ester containing a total of at least 7 carbon atoms from a flow of ammonium lactate, characterized in that reactive distillation is performed, on a column, on a flow of ammonium lactate in liquid form, pre-purified by: a) removing the biomass; b) decationizing the fermentation liquor on an ion exchange resin previously conditioned in ammoniacal form; c) nanofiltering the decationized liquor, and said pre-purified lactate also being concentrated, simultaneously with a flow of an aliphatic alcohol having 4 to 8 carbon atoms, in vapour form, a corresponding liquid flow of lactic ester being recovered at the foot of the column and a gaseous mixture comprising the aliphatic alcohol, ammonia and water being recovered at the head of the column. a) removing the biomass; b) decationizing the fermentation liquor on an ion exchange resin previously conditioned in ammoniacal form; c) nanofiltering the decationized liquor,
Method for determining whether a subject having a melanoma has a poor prognosis, the method comprising the step of determining in a sample from the subject whether the LY75 promoter is methylated and if the LY75 promoter is methylated, classifying the subject as having a poor prognosis, wherein the sample is a melanoma sample.
A polypeptide which specifically binds to LRP5 and LRP6, comprising - a first immunoglobulin single variable domain selected from the group of immunoglobulin single variable domains (i) to (iii) defined by comprising the following CDR sequences: (i): CDR1: TYTVG (= SEQ ID NO:1) CDR2: AIRRRGSSTYYADSVKG (= SEQ ID NO:2) CDR3: DTRTVALLQYRYDY (= SEQ ID NO:3) (ii): CDR1: SYAMG (= SEQ ID NO:4) CDR2: AIRRSGRRTYYADSVKG (= SEQ ID NO:5) CDR3: ARRVRSSTRYNTGTWWWEY (= SEQ ID NO:6) (iii): CDR1: RYTMG (= SEQ ID NO:7) CDR2: AIVRSGGSTYYADSVKG (= SEQ ID NO:8) CDR3: DRRGRGENYILLYSSGRYEY (= SEQ ID NO:9), and - a second immunoglobulin single variable domain selected from the group of immunoglobulin single variable domains (iv) and (v) defined by comprising the following CDR sequences: (iv): CDR1: SYAMG (= SEQ ID NO:10) CDR2: AISWSGGSTYYADSVKG (= SEQ ID NO:11) CDR3: SPIPYGSLLRRRNNYDY (= SEQ ID NO:12) (v): CDR1: SYAMG (= SEQ ID NO:13) CDR2: AISWRSGSTYYADSVKG (= SEQ ID NO:14) CDR3: DPRGYGVAYVSAYYEY (= SEQ ID NO:15). - a first immunoglobulin single variable domain selected from the group of immunoglobulin single variable domains (i) to (iii) defined by comprising the following CDR sequences: (i): CDR1: TYTVG (= SEQ ID NO:1) CDR2: AIRRRGSSTYYADSVKG (= SEQ ID NO:2) CDR3: DTRTVALLQYRYDY (= SEQ ID NO:3) (ii): CDR1: SYAMG (= SEQ ID NO:4) CDR2: AIRRSGRRTYYADSVKG (= SEQ ID NO:5) CDR3: ARRVRSSTRYNTGTWWWEY (= SEQ ID NO:6) (iii): CDR1: RYTMG (= SEQ ID NO:7) CDR2: AIVRSGGSTYYADSVKG (= SEQ ID NO:8) CDR3: DRRGRGENYILLYSSGRYEY (= SEQ ID NO:9), and (i): CDR1: TYTVG (= SEQ ID NO:1) CDR2: AIRRRGSSTYYADSVKG (= SEQ ID NO:2) CDR3: DTRTVALLQYRYDY (= SEQ ID NO:3) (ii): CDR1: SYAMG (= SEQ ID NO:4) CDR2: AIRRSGRRTYYADSVKG (= SEQ ID NO:5) CDR3: ARRVRSSTRYNTGTWWWEY (= SEQ ID NO:6) (iii): CDR1: RYTMG (= SEQ ID NO:7) CDR2: AIVRSGGSTYYADSVKG (= SEQ ID NO:8) CDR3: DRRGRGENYILLYSSGRYEY (= SEQ ID NO:9), and - a second immunoglobulin single variable domain selected from the group of immunoglobulin single variable domains (iv) and (v) defined by comprising the following CDR sequences: (iv): CDR1: SYAMG (= SEQ ID NO:10) CDR2: AISWSGGSTYYADSVKG (= SEQ ID NO:11) CDR3: SPIPYGSLLRRRNNYDY (= SEQ ID NO:12) (v): CDR1: SYAMG (= SEQ ID NO:13) CDR2: AISWRSGSTYYADSVKG (= SEQ ID NO:14) CDR3: DPRGYGVAYVSAYYEY (= SEQ ID NO:15). (iv): CDR1: SYAMG (= SEQ ID NO:10) CDR2: AISWSGGSTYYADSVKG (= SEQ ID NO:11) CDR3: SPIPYGSLLRRRNNYDY (= SEQ ID NO:12) (v): CDR1: SYAMG (= SEQ ID NO:13) CDR2: AISWRSGSTYYADSVKG (= SEQ ID NO:14) CDR3: DPRGYGVAYVSAYYEY (= SEQ ID NO:15).
An arc chute assembly comprising: a housing having an axis (a) the housing comprising a pair of housing members (204,206) and further comprising a stability member assembled together with each housing member; an arc runner plate supported by the housing, wherein the arc runner further comprises a protrusion configured to disallow reverse assembly of the arc chamber in a circuit breaker; a quenching portion disposed within the housing, the quenching portion comprising: at least two deion plates being spaced along the axis (a) of the housing and each having a cut portion wherein the cut portions are staggered along the axis (a) with respect to one another and are configured to mitigate an arc. a housing having an axis (a) the housing comprising a pair of housing members (204,206) and further comprising a stability member assembled together with each housing member; an arc runner plate supported by the housing, wherein the arc runner further comprises a protrusion configured to disallow reverse assembly of the arc chamber in a circuit breaker; a quenching portion disposed within the housing, the quenching portion comprising: at least two deion plates being spaced along the axis (a) of the housing and each having a cut portion wherein the cut portions are staggered along the axis (a) with respect to one another and are configured to mitigate an arc. at least two deion plates being spaced along the axis (a) of the housing and each having a cut portion wherein the cut portions are staggered along the axis (a) with respect to one another and are configured to mitigate an arc.
A process for producing lipid nanoparticles encapsulating therapeutic products, said process comprising: a) providing one or more aqueous solutions in one or more reservoirs; b) providing one or more organic solutions in one or more reservoirs, wherein one or more of the organic solutions contains a lipid and wherein one or more of the aqueous solutions and/or one or more of the organic solutions includes therapeutic products; and c) mixing said one or more aqueous solutions with said one or more organic solutions in a first mixing region, wherein said first mixing region is a Multi-Inlet Vortex Mixer (MIVM), wherein said one or more aqueous solutions and said one or more organic solutions are introduced tangentially into a mixing chamber within the MIVM so as to instantaneously produce a lipid nanoparticle solution containing lipid nanoparticles encapsulating therapeutic products. a) providing one or more aqueous solutions in one or more reservoirs; b) providing one or more organic solutions in one or more reservoirs, wherein one or more of the organic solutions contains a lipid and wherein one or more of the aqueous solutions and/or one or more of the organic solutions includes therapeutic products; and c) mixing said one or more aqueous solutions with said one or more organic solutions in a first mixing region, wherein said first mixing region is a Multi-Inlet Vortex Mixer (MIVM), wherein said one or more aqueous solutions and said one or more organic solutions are introduced tangentially into a mixing chamber within the MIVM so as to instantaneously produce a lipid nanoparticle solution containing lipid nanoparticles encapsulating therapeutic products.
A method of verifying the validity of a digital signature based on biometric data, the digital signature created using an enrollment biometric template of an individual associated with the signature by signing a message with a secret key of the individual, the method comprising the steps of: - attaining a verification biometric template of an individual to be verified; - receiving the digital signature; and - verifying the digital signature; characterized in that the method comprises - receiving the enrollment biometric template, - comparing the verification biometric template with the enrollment biometric template, wherein the verification of the digital signature is considered to be valid if the verification template corresponds to the enrollment template according to a predetermined similarity measure, - said verifying the digital signature by means of using the enrollment biometric template as a public key, - the secret key of the individual having been created by running a user-key generation algorithm on a secret master key and the enrollment biometric template, and - storing the secret key of the individual and the enrollment biometric template on a device used by the individual for verification purposes. - attaining a verification biometric template of an individual to be verified; - receiving the digital signature; and - verifying the digital signature; characterized in that the method comprises - receiving the enrollment biometric template, - comparing the verification biometric template with the enrollment biometric template, wherein the verification of the digital signature is considered to be valid if the verification template corresponds to the enrollment template according to a predetermined similarity measure, - said verifying the digital signature by means of using the enrollment biometric template as a public key, - the secret key of the individual having been created by running a user-key generation algorithm on a secret master key and the enrollment biometric template, and - storing the secret key of the individual and the enrollment biometric template on a device used by the individual for verification purposes.
A method of preventing the occurrence of fraud in the acquisition of an individual's biometric data, the method comprising: - a first acquisition step (E1; E10) comprising using a biometric sensor (1; 10) to acquire first biometric data of the individual, representative of a first morphological characteristic of the individual comprising fingerprints of fingers of a hand of the individual; - a second acquisition step (E2; E11) comprising using a camera distinct from the biometric sensor to acquire at least one context image comprising a first image portion representative of said first morphological characteristic and a second image portion representative of the entire hand together with a zone surrounding the hand; - an extraction step comprising extracting second biometric data representative of the first morphological characteristic from the first image portion; and - verification steps comprising: o verifying that both said data come from the same hand of the same individual by comparing the first biometric data with the second biometric data, o verifying that the fingers belong to one single hand by analyzing the second image portion based on the outline of the hand, and o verifying that a fake finger or a portion of a fake finger has not been used by detecting a discontinuity in the second image portion between phalanges of the fingers. - a first acquisition step (E1; E10) comprising using a biometric sensor (1; 10) to acquire first biometric data of the individual, representative of a first morphological characteristic of the individual comprising fingerprints of fingers of a hand of the individual; - a second acquisition step (E2; E11) comprising using a camera distinct from the biometric sensor to acquire at least one context image comprising a first image portion representative of said first morphological characteristic and a second image portion representative of the entire hand together with a zone surrounding the hand; - an extraction step comprising extracting second biometric data representative of the first morphological characteristic from the first image portion; and - verification steps comprising: o verifying that both said data come from the same hand of the same individual by comparing the first biometric data with the second biometric data, o verifying that the fingers belong to one single hand by analyzing the second image portion based on the outline of the hand, and o verifying that a fake finger or a portion of a fake finger has not been used by detecting a discontinuity in the second image portion between phalanges of the fingers. o verifying that both said data come from the same hand of the same individual by comparing the first biometric data with the second biometric data, o verifying that the fingers belong to one single hand by analyzing the second image portion based on the outline of the hand, and o verifying that a fake finger or a portion of a fake finger has not been used by detecting a discontinuity in the second image portion between phalanges of the fingers.
An apparatus for generating a hybrid image by high dynamic range counting, characterized by comprising: processing circuitry configured to acquire an image from a pixelated detector, obtain a sparsity map of the acquired image, the sparsity map indicating low-flux regions of the acquired image and high-flux regions of the acquired image, generate a low-flux image and a high-flux image based on the sparsity map, perform event analysis of the acquired image based on the low-flux image and the high-flux image, the event analysis including detecting, within the low-flux image, incident events by an electron counting mode, multiply, by a normalization constant, resulting intensities of the high-flux image and the detected incident events of the low-flux image, the multiplying normalizing intensity per detected incident event between the low-flux image and the high-flux image, and generate the hybrid image by merging the low-flux image and the high-flux image. acquire an image from a pixelated detector, obtain a sparsity map of the acquired image, the sparsity map indicating low-flux regions of the acquired image and high-flux regions of the acquired image, generate a low-flux image and a high-flux image based on the sparsity map, perform event analysis of the acquired image based on the low-flux image and the high-flux image, the event analysis including detecting, within the low-flux image, incident events by an electron counting mode, multiply, by a normalization constant, resulting intensities of the high-flux image and the detected incident events of the low-flux image, the multiplying normalizing intensity per detected incident event between the low-flux image and the high-flux image, and generate the hybrid image by merging the low-flux image and the high-flux image.
A platform door device comprising a door, a driving mechanism for moving the door forwardly and backwardly to close and open a gate on a platform, a guide body installable on the platform, and a guiding mechanism for guiding the door being moved forwardly or backwardly, the guiding mechanism including a linear rail extending in a direction of a movement of the door, and a guide block adapted to be slidingly moved with respect to the linear rail; wherein: the driving mechanism includes a motor that is fixed to the guide body, a rotation body adapted to be rotated by the motor, and a driven body adapted to be driven according to the rotation of the rotation body so as to move the door; the door includes a panel-shaped main body, and a base segment which is detachably joined to the main body and to which the driven body is attached; the main body includes a frame assembly having a lower frame; wherein the base segment includes a mounting portion having an upper section and a lower section, a joining portion extending upwardly from a widthwise intermediate region of the upper section, and a bridging portion bridged between an upper end of the joining portion and an end of the upper section of the mounting portion; one of the linear rail and the guide block is attached to the lower section of the mounting portion, and the remaining one of the linear rail and the guide block is fixed to the guide body; a lateral surface of the joining portion is joined to a lateral surface of the lower frame of the frame assembly with a bolt from a lateral direction. the driving mechanism includes a motor that is fixed to the guide body, a rotation body adapted to be rotated by the motor, and a driven body adapted to be driven according to the rotation of the rotation body so as to move the door; the door includes a panel-shaped main body, and a base segment which is detachably joined to the main body and to which the driven body is attached; the main body includes a frame assembly having a lower frame; wherein the base segment includes a mounting portion having an upper section and a lower section, a joining portion extending upwardly from a widthwise intermediate region of the upper section, and a bridging portion bridged between an upper end of the joining portion and an end of the upper section of the mounting portion; one of the linear rail and the guide block is attached to the lower section of the mounting portion, and the remaining one of the linear rail and the guide block is fixed to the guide body; a lateral surface of the joining portion is joined to a lateral surface of the lower frame of the frame assembly with a bolt from a lateral direction.
An acoustic wave device comprising: a piezoelectric substance (20, 34); an electrode configured to excite an acoustic wave and located on the piezoelectric substance, or electrodes (32, 36) configured to excite an acoustic wave and located so as to sandwich the piezoelectric substance; and a silicon oxide film (26, 38) that is located so as to cover the electrode located on the piezoelectric substance or is located in a region where the electrodes (32, 36) sandwiching the piezoelectric substance face each other, and is doped with an element or molecule displacing O in a Si-O bond, wherein the element or molecule is F, H, CH 3, CH 2, Cl, C, N, P, or S, and characterized in that the silicon oxide film (26, 38) doped with the element or molecule has a peak wave number of a Si-O bond stretching vibration larger than that of a silicon oxide film that is not doped with the element or molecule, the peak wave number being defined as a wave number of infrared light at which the absorption reaches a maximum. a piezoelectric substance (20, 34); an electrode configured to excite an acoustic wave and located on the piezoelectric substance, or electrodes (32, 36) configured to excite an acoustic wave and located so as to sandwich the piezoelectric substance; and a silicon oxide film (26, 38) that is located so as to cover the electrode located on the piezoelectric substance or is located in a region where the electrodes (32, 36) sandwiching the piezoelectric substance face each other, and is doped with an element or molecule displacing O in a Si-O bond, wherein the element or molecule is F, H, CH 3, CH 2, Cl, C, N, P, or S, and characterized in that the silicon oxide film (26, 38) doped with the element or molecule has a peak wave number of a Si-O bond stretching vibration larger than that of a silicon oxide film that is not doped with the element or molecule, the peak wave number being defined as a wave number of infrared light at which the absorption reaches a maximum.
A pharmaceutical composition for use in the treatment or prophylaxis of an IgE-mediated allergic disease, which comprises bryostatin 1 to induce selective IgA class switching in B cells, wherein the IgE-mediated allergic disease is selected from the group consisting of atopic dermatitis, allergic rhinitis, allergic conjunctivitis, allergic gastroenteritis, food allergy, drug allergy, and urticaria.
Electrical coupling device for electrically and mechanically coupling a power conducting device of an electrical system to an electrical installation of the electrical system, comprising an electrical conductor device having a first electrical conductor portion for electrical connection to an electrical conductor connecting portion of a power conductor of the power conducting device and also having a second electrical conductor portion for electrical connection to an electrical installation connecting portion of the electrical installation, wherein the electrical conductor device has a connecting conductor for electrically coupling the first electrical conductor portion to the second electrical conductor portion, comprising an insulating cone having a central bushing, wherein a subregion of the electrical conductor device is arranged in the central bushing, and also comprising a mechanical connection device having a first mechanical connecting portion for mechanical connection to a pipe connecting portion of an insulation pipe of the power conducting device and having a second mechanical connecting portion for mechanical connection to a housing joining portion of an installation housing of the electrical installation, characterized in that the first mechanical connecting portion is designed for welding to the pipe connecting portion, wherein the first mechanical connecting portion contains a thermoplastic or is formed from a thermoplastic. wherein a subregion of the electrical conductor device is arranged in the central bushing, and also comprising a mechanical connection device having a first mechanical connecting portion for mechanical connection to a pipe connecting portion of an insulation pipe of the power conducting device and having a second mechanical connecting portion for mechanical connection to a housing joining portion of an installation housing of the electrical installation, characterized in that the first mechanical connecting portion is designed for welding to the pipe connecting portion, wherein the first mechanical connecting portion contains a thermoplastic or is formed from a thermoplastic.
A bimodal polymer having a weight fraction of a lower molecular weight component ranging from about 0.25 to about 0.45, a weight fraction of a higher molecular weight component ranging from about 0.55 to about 0.75 and a density of from greater than 0.940 g/cc to about 0.955 g/cc which when tested in accordance with ASTM D1003 has a percentage haze less than about 40%.